Machine-learning Treg framework identifies SMARCC1 as a previously unrecognized regulator
A framework combining single-cell ATAC-seq, motif analysis, topic modeling, machine learning and genetic variation identified SMARCC1 as a previously unrecognized controller of regulatory T-cell chromatin programs. CRISPR-Cas9 deletion of Smarcc1 in Tregs produced the predicted loss of accessibility in topic-3 regulatory regions, supporting the computationally inferred connection.
Technology: Integrated machine-learning framework using topic modeling and high-density genetic variation over single-cell ATAC-seq profiles
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: A framework combining single-cell ATAC-seq, motif analysis, topic modeling, machine learning and genetic variation identified SMARCC1 as a previously unrecognized controller of regulatory T-cell chromatin programs.
- Still unknown: CRISPR validation supported the predicted SMARCC1 effect for topic 3; topic 10 was not represented and the authors note possible redundancy with SMARCC2. The result concerns regulatory chromatin programs in Tregs, not clinical or therapeutic outcomes.
- AI role: The framework organized co-varying open chromatin regions into Treg regulatory modules, inferred transcription-factor effects on those programs, and nominated SMARCC1 as a regulator of topic-3/10 accessibility. The team tested the prediction by CRISPR-Cas9 editing Tregs and profiling chromatin accessibility.
Evidence sources: https://cbdm.hms.harvard.edu/assets/Publications/2024pub/chowdharyPNAS.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 32 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.